On Wednesday, the stock made up almost at Can$0.0188 during the four days; it has stayed stable. On July 12, the stock equaled at Can$0.0185 and rapidly dipped by 18% on the same day. Yesterday the stock fantastically skyrocketed to Can$0.0220. At the time of writing, it gains momentum. The general market capitalization is 721,184. The EUA procedure has commenced, and the company is preparing to file a 510k. A 510(k) is a premarket submission to the FDA that demonstrates that the device to be marketed is safe and effective, or substantially equal to a legally marketed device (FD&C Act section 513(i)(1)(A)). Bacteria Scientific is assessing CLIA laboratories to undertake third-party testing of live pathogens given by the CDC and FDA as part of this procedure.
Future versions of the completely automated high-tech gadget, which is now under development, will have a more diminutive form that will speedier test results while maintaining the same anticipated accuracy of 98 percent or higher. The second-generation gadget will take viral reagent-specific testing tubes and will be able to screen for COVID-19, MERS, TB, Zika Virus, Influenza variations, Human Metapneumovirus, and many more respiratory viruses.